1. Market Research
  2. > Healthcare Market Trends
  3. > Qatar Pharmaceuticals and Healthcare Report Q4 2015

Qatar Pharmaceuticals and Healthcare Report Q4 2015

  • September 2015
  • -
  • Business Monitor International
  • -
  • 105 pages

Includes 3 FREE quarterly updates

BMI View: The roll out of Qatar's mandatory health insurance scheme will provide commercialopportunities for private healthcare providers, drugmakers, and medical devices and infrastructurecompanies. Expansion projects are already underway and in the pipeline in a bid to take advantage of therapidly increasing demand for healthcare services.

Headline Expenditure Projections

- Pharmaceuticals: QAR1.79bn (USD491mn) in 2014 to QAR2.00bn (USD548mn) in 2015; +11.5% inlocal currency and US dollar terms. Forecast downgraded from Q315.
- Healthcare: QAR17.25bn (USD4.74bn) in 2014 to QAR18.86bn (USD5.19bn) in 2015; +9.3% in bothlocal currency and US dollar terms. Forecast in line with Q315.

Table Of Contents

Qatar Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Qatar 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Qatar 2011-2019) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Qatar 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Qatar 2011-2019) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Qatar 2011-2019) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Qatar 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Qatar 2011-2019) 25
OTC Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Qatar 2011-2019) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Qatar 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Qatar 2013-2019) 30
Key Risks To BMI's Forecast Scenario 31
Macroeconomic Forecasts 34
Table: BMI And Bloomberg Consensus Forecasts - Brent 35
Expenditure Breakdown 37
Industry Risk Reward Indices 42
Middle East and Africa Risk/Reward Index 42
Qatar Risk/Reward Index 49
Rewards 49
Risks 49
Market Overview 51
Industry Trends And Developments 52
Epidemiology 52
Healthcare Sector 57
Healthcare Sector Developments 58
GCC Unified Drug Pricing 61
Table: Healthcare Resources (Qatar 2009-2014) 62
Table: Healthcare Personnel (Qatar 2009-2014) 62
Table: Healthcare Activity (Qatar 2009-2014) 63
Health Insurance 63
Healthcare IT 66
Research and Development 67
Clinical Trials 69
Regulatory Development 70
Regional Regulatory Developments 71
Intellectual Property Regime 74
Pricing And Reimbursement Regime 74
Competitive Landscape 77
Pharmaceutical Industry 77
Pharmaceutical Wholesale And Retail 79
Company Profile 80
Ebn Sina Medical 80
GlaxoSmithKline 82
Medicare Group 84
Merck and Co 86
Novartis 88
Pfizer 90
Qatar Pharma 92
Demographic Forecast 94
Demographic Outlook 94
Table: Population Headline Indicators (Qatar 1990-2025) 95
Table: Key Population Ratios (Qatar 1990-2025) 95
Table: Urban/Rural Population and Life Expectancy (Qatar 1990-2025) 96
Table: Population By Age Group (Qatar 1990-2025) 96
Table: Population By Age Group % (Qatar 1990-2025) 97
Glossary 99
Methodology 101
Pharmaceutical Expenditure Forecast Model 101
Healthcare Expenditure Forecast Model 101
Notes On Methodology 102
Risk/Reward Index Methodology 103
Index Overview 104
Table: Pharmaceutical Risk/Reward Index Indicators 104
Indicator Weightings 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

  • $ 7 150
  • Industry report
  • May 2016
  • by MarketsandMarkets

The wound care market in terms of value is expected to reach USD 20.4 billion by 2021 from USD 17.0 billion in 2016, growing at a CAGR of 3.6% from 2016 to 2021. This market is categorized on the basis ...

Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.